326 related articles for article (PubMed ID: 14668072)
1. Surveillance of smokeless tobacco nicotine, pH, moisture, and unprotonated nicotine content.
Richter P; Spierto FW
Nicotine Tob Res; 2003 Dec; 5(6):885-9. PubMed ID: 14668072
[TBL] [Abstract][Full Text] [Related]
2. Surveillance of moist snuff: total nicotine, moisture, pH, un-ionized nicotine, and tobacco-specific nitrosamines.
Richter P; Hodge K; Stanfill S; Zhang L; Watson C
Nicotine Tob Res; 2008 Nov; 10(11):1645-52. PubMed ID: 18988077
[TBL] [Abstract][Full Text] [Related]
3. Notice regarding requirement for annual submission of the quantity of nicotine contained in smokeless tobacco products manufactured, imported, or packaged in the United States. Centers for Disease Control and Prevention (CDC), Department of Health and Human Services. Notice.
Fed Regist; 1999 Mar; 64(55):14085-96. PubMed ID: 10558405
[TBL] [Abstract][Full Text] [Related]
4. Determination of nicotine, pH, and moisture content of six U.S. commercial moist snuff products--Florida, January-February 1999.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1999 May; 48(19):398-401. PubMed ID: 10366135
[TBL] [Abstract][Full Text] [Related]
5. Free nicotine content and strategic marketing of moist snuff tobacco products in the United States: 2000-2006.
Alpert HR; Koh H; Connolly GN
Tob Control; 2008 Oct; 17(5):332-8. PubMed ID: 18669556
[TBL] [Abstract][Full Text] [Related]
6. Five leading U.S. commercial brands of moist snuff in 1994: assessment of carcinogenic N-nitrosamines.
Hoffmann D; Djordjevic MV; Fan J; Zang E; Glynn T; Connolly GN
J Natl Cancer Inst; 1995 Dec; 87(24):1862-9. PubMed ID: 7494230
[TBL] [Abstract][Full Text] [Related]
7. Chemical profile of two types of oral snuff tobacco.
Brunnemann KD; Qi J; Hoffmann D
Food Chem Toxicol; 2002 Nov; 40(11):1699-703. PubMed ID: 12176096
[TBL] [Abstract][Full Text] [Related]
8. New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels.
Stepanov I; Jensen J; Hatsukami D; Hecht SS
Nicotine Tob Res; 2008 Dec; 10(12):1773-82. PubMed ID: 19023828
[TBL] [Abstract][Full Text] [Related]
9. Use of smokeless tobacco among adults--United States, 1991.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1993 Apr; 42(14):263-6. PubMed ID: 8459796
[TBL] [Abstract][Full Text] [Related]
10. Approaches, challenges, and experience in assessing free nicotine.
Ashley DL; Pankow JF; Tavakoli AD; Watson CH
Handb Exp Pharmacol; 2009; (192):437-56. PubMed ID: 19184658
[TBL] [Abstract][Full Text] [Related]
11. Smokeless tobacco products sold in Massachusetts from 2003 to 2012: trends and variations in brand availability, nicotine contents and design features.
Cullen D; Keithly L; Kane K; Land T; Paskowsky M; Chen L; Hayes R; Li W
Tob Control; 2015 May; 24(3):256-62. PubMed ID: 24420311
[TBL] [Abstract][Full Text] [Related]
12. Global surveillance of oral tobacco products: total nicotine, unionised nicotine and tobacco-specific N-nitrosamines.
Stanfill SB; Connolly GN; Zhang L; Jia LT; Henningfield JE; Richter P; Lawler TS; Ayo-Yusuf OA; Ashley DL; Watson CH
Tob Control; 2011 May; 20(3):e2. PubMed ID: 21109685
[TBL] [Abstract][Full Text] [Related]
13. Chemical characterization of domestic oral tobacco products: total nicotine, pH, unprotonated nicotine and tobacco-specific N-nitrosamines.
Lawler TS; Stanfill SB; Zhang L; Ashley DL; Watson CH
Food Chem Toxicol; 2013 Jul; 57():380-6. PubMed ID: 23517910
[TBL] [Abstract][Full Text] [Related]
14. Snuffing out cigarette sales and the smoking deaths epidemic.
Laugesen M
N Z Med J; 2007 Jun; 120(1256):U2587. PubMed ID: 17589555
[TBL] [Abstract][Full Text] [Related]
15. Brand specific responses to smokeless tobacco in a rat lip canal model.
Schwartz JL; Brunnemann KD; Adami AJ; Panda S; Gordon SC; Hoffmann D; Adami GR
J Oral Pathol Med; 2010 Jul; 39(6):453-9. PubMed ID: 20642753
[TBL] [Abstract][Full Text] [Related]
16. National Institutes of Health consensus statement. Health implications of smokeless tobacco use. NIH Consensus Development Panel.
Biomed Pharmacother; 1988; 42(2):93-8. PubMed ID: 3048429
[TBL] [Abstract][Full Text] [Related]
17. Nicotine delivery capabilities of smokeless tobacco products and implications for control of tobacco dependence in South Africa.
Ayo-Yusuf OA; Swart TJ; Pickworth WB
Tob Control; 2004 Jun; 13(2):186-9. PubMed ID: 15175538
[TBL] [Abstract][Full Text] [Related]
18. Changing smokeless tobacco products new tobacco-delivery systems.
Hatsukami DK; Ebbert JO; Feuer RM; Stepanov I; Hecht SS
Am J Prev Med; 2007 Dec; 33(6 Suppl):S368-78. PubMed ID: 18021912
[TBL] [Abstract][Full Text] [Related]
19. Smokeless tobacco use by youth: a health concern.
Johnson GK; Squier CA
Pediatr Dent; 1993; 15(3):169-74. PubMed ID: 8378153
[TBL] [Abstract][Full Text] [Related]
20. Toxic and carcinogenic agents in dry and moist snuff.
Hoffmann D; Adams JD; Lisk D; Fisenne I; Brunnemann KD
J Natl Cancer Inst; 1987 Dec; 79(6):1281-6. PubMed ID: 3480379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
